• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏对具有浓度依赖性血清蛋白结合的药物的消除作用。

Hepatic elimination of drugs with concentration-dependent serum protein binding.

作者信息

Huang J D, Oie S

出版信息

J Pharmacokinet Biopharm. 1984 Feb;12(1):67-81. doi: 10.1007/BF01063611.

DOI:10.1007/BF01063611
PMID:6747819
Abstract

For a drug with concentration-dependent serum protein binding, the unbound fraction of drug decreases during the drug elimination process. The clearance of the drug at a given blood flow rate is lower than would be expected from the observed unbound fraction in venous blood from a noneliminating organ. Based on both the "well-stirred" and "parallel tube" models, simulations demonstrated that consideration of concentration-dependent binding during drug elimination is important when the intrinsic clearance is higher than the blood flow and when the unbound drug concentration is much greater than the dissociation equilibrium constant of the binding complex.

摘要

对于具有浓度依赖性血清蛋白结合的药物,在药物消除过程中,药物的游离分数会降低。在给定血流速率下,该药物的清除率低于根据非消除器官静脉血中观察到的游离分数所预期的值。基于“充分搅拌”模型和“平行管”模型的模拟表明,当内在清除率高于血流速率且游离药物浓度远大于结合复合物的解离平衡常数时,在药物消除过程中考虑浓度依赖性结合很重要。

相似文献

1
Hepatic elimination of drugs with concentration-dependent serum protein binding.肝脏对具有浓度依赖性血清蛋白结合的药物的消除作用。
J Pharmacokinet Biopharm. 1984 Feb;12(1):67-81. doi: 10.1007/BF01063611.
2
Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.通过“试管”模型和“充分搅拌”模型评估血浆蛋白结合动力学对肝脏清除率的影响。
J Pharmacokinet Biopharm. 1981 Feb;9(1):15-26. doi: 10.1007/BF01059340.
3
Determination of hepatic clearance with the account of drug-protein binding kinetics.测定肝清除率时需考虑药物蛋白结合动力学。
J Pharm Sci. 2012 Oct;101(10):3936-45. doi: 10.1002/jps.23235. Epub 2012 Jul 5.
4
First-in-Human Predictions of Hepatic Clearance for Drugs With the Well-Stirred Model: Comparative Assessment Between Models of Fraction Unbound Based Either on the Free Drug Hypothesis, Albumin-Facilitated Hepatic Uptake or Dynamic Binding Kinetics.基于自由药物假说、白蛋白促进肝摄取或动态结合动力学的分数未结合模型预测具有搅拌池模型的药物在人体内的肝清除率:模型比较评估。
J Pharm Sci. 2024 Aug;113(8):2641-2650. doi: 10.1016/j.xphs.2024.05.021. Epub 2024 May 24.
5
Commentary: a physiological approach to hepatic drug clearance.述评:肝脏药物清除的生理学方法
Clin Pharmacol Ther. 1975 Oct;18(4):377-90. doi: 10.1002/cpt1975184377.
6
Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.直接测定血浆中游离分数与微粒体系统中游离分数的比值(fu p/fu mic),以精确预测I相介导的肝脏代谢清除率。
J Pharmacol Toxicol Methods. 2011 Jan-Feb;63(1):35-9. doi: 10.1016/j.vascn.2010.04.003. Epub 2010 Apr 28.
7
Membrane transport in hepatic clearance of drugs. II: Zonal distribution patterns of concentration-dependent transport and elimination processes.药物肝清除中的膜转运。II:浓度依赖性转运和消除过程的区域分布模式。
Pharm Res. 1997 Jun;14(6):780-5. doi: 10.1023/a:1012158607766.
8
Introducing the Dynamic Well-Stirred Model for Predicting Hepatic Clearance and Extraction Ratio.介绍用于预测肝脏清除率和提取率的动态搅拌模型。
J Pharm Sci. 2024 Apr;113(4):1094-1112. doi: 10.1016/j.xphs.2023.12.020. Epub 2024 Jan 12.
9
Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation.蛋白结合和肝清除率:再探讨在离体灌流大鼠肝脏模型中,用地西泮评价肝清除率模型的区分度。
Drug Metab Dispos. 2019 Dec;47(12):1397-1402. doi: 10.1124/dmd.119.088872. Epub 2019 Sep 28.
10
Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.在缺乏白蛋白的情况下从体外推导出药物的肝脏清除率,到体内存在白蛋白的情况下:基于白蛋白介导的肝摄取理论的 2 种外推模型的比较评估及其局限性和机制见解。
J Pharm Sci. 2018 Jul;107(7):1791-1797. doi: 10.1016/j.xphs.2018.03.012. Epub 2018 Mar 20.

引用本文的文献

1
Age-related changes in protein binding of drugs: implications for therapy.药物蛋白结合的年龄相关变化:对治疗的影响。
Clin Pharmacokinet. 2000 Mar;38(3):271-90. doi: 10.2165/00003088-200038030-00005.
2
Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal.非线性蛋白质结合与酶的异质性:对肝脏药物清除的影响。
J Pharmacokinet Biopharm. 1993 Feb;21(1):43-74. doi: 10.1007/BF01061775.
3
Saturable elimination and saturable protein binding account for flavone acetic acid pharmacokinetics.饱和消除和饱和蛋白结合决定了黄酮醋酸的药代动力学。

本文引用的文献

1
Effect of plasma protein and tissue binding on the time course of drug concentration in plasma.血浆蛋白和组织结合对血浆中药物浓度时程的影响。
J Pharmacokinet Biopharm. 1979 Apr;7(2):195-206. doi: 10.1007/BF01059738.
2
Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.通过“试管”模型和“充分搅拌”模型评估血浆蛋白结合动力学对肝脏清除率的影响。
J Pharmacokinet Biopharm. 1981 Feb;9(1):15-26. doi: 10.1007/BF01059340.
3
Effect of saturable binding on the pharmacokinetics of drugs: a simulation.
J Pharmacokinet Biopharm. 1993 Dec;21(6):639-51. doi: 10.1007/BF01113499.
4
Competition between two enzymes for substrate removal in liver: modulating effects due to substrate recruitment of hepatocyte activity.肝脏中两种酶对底物清除的竞争:肝细胞活性底物募集的调节作用。
J Pharmacokinet Biopharm. 1987 Oct;15(5):473-96. doi: 10.1007/BF01061758.
可饱和结合对药物药代动力学的影响:一项模拟研究
J Pharm Pharmacol. 1980 Jul;32(7):471-7. doi: 10.1111/j.2042-7158.1980.tb12971.x.
4
Clearance concepts in pharmacokinetics.药代动力学中的清除概念。
J Pharmacokinet Biopharm. 1973 Apr;1(2):123-36. doi: 10.1007/BF01059626.
5
Commentary: a physiological approach to hepatic drug clearance.述评:肝脏药物清除的生理学方法
Clin Pharmacol Ther. 1975 Oct;18(4):377-90. doi: 10.1002/cpt1975184377.
6
Theoretic aspects of pharmacokinetic drug interactions.药物动力学药物相互作用的理论方面。
Clin Pharmacol Ther. 1977 Nov;22(5 Pt 2):623-39. doi: 10.1002/cpt1977225part2623.
7
Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.药物的肝清除率。I. “充分搅拌”模型和“平行管”模型的理论考量。肝血流量、血浆和血细胞结合以及肝细胞酶活性对肝药物清除率的影响。
J Pharmacokinet Biopharm. 1977 Dec;5(6):625-53. doi: 10.1007/BF01059688.